title: Cell cycle alterations, apoptosis, and response to low-dose-rate radioimmunotherapy in lymphoma cells.
abstract: OBJECTIVE
  In an attempt to elucidate some aspects of the radiobiological basis of radioimmunotherapy, we have evaluated the in vitro cellular response patterns for malignant lymphoma cell lines exposed to high- and low-dose-rate radiation administered within the physiological context of antibody cell-surface binding.
  
  
  METHODS
  We used two different malignant lymphoma cell lines, a Thy1.2+ murine T-lymphoma line called EL-4 and a CD20+ human B-lymphoma line called Raji. Cells were grown in suspension cultures and exposed to high-dose-rate gamma radiation from an external 137Cs source or low-dose-rate beta radiation from DTPA-solubilized 90Y in solution. In some experiments, cells were pre-incubated with an excess of nonradioactive antibody in order to assess the effects of immunoglobulin surface binding during radiation exposure. Irradiated cells were evaluated for viability, cell-cycle changes, patterns of post-radiation morphologic changes, and biochemical hallmarks of radiation-associated necrosis and programmed cell death.
  
  
  RESULTS
  The EL-4 line was sensitive to both high-dose-rate and low-dose-rate irradiation, while the Raji showed efficient cell kill only after high-dose-rate irradiation. Studies of radiation-induced cell cycle changes demonstrated that both cell lines were efficiently blocked at the G2/M interface by high-dose-rate irradiation, with the Raji cells appearing somewhat more susceptible than the EL-4 cells to low-dose-rate radiation-induced G2/M block. Electron microscopy and DNA gel electrophoresis studies showed that a significant proportion of the EL-4 cells appeared to be dying by radiation-induced programmed cell death (apoptosis) while the Raji cells appeared to be dying primarily by classical radiation-induced cellular necrosis.
  
  
  CONCLUSIONS
  We propose that the unusual clinical responsiveness of some high and low grade lymphomas to modest doses of low-dose-rate radioimmunotherapy may be explained in part by the induction of apoptosis. The unusual dose-response characteristics observed in some experimental models of radiation-induced apoptosis may require a reappraisal of standard linear quadratic and alpha/beta algorithms used to predict target tissue cytoreduction after radioimmunotherapy.
authors.affiliation: Harvard Joint Center for Radiation Therapy, Boston, MA 02115.
authors.forename: R M
authors.initials: RM
authors.lastname: Macklis
authors.forename: B A
authors.initials: BA
authors.lastname: Beresford
authors.forename: S
authors.initials: S
authors.lastname: Palayoor
authors.forename: S
authors.initials: S
authors.lastname: Sweeney
authors.forename: J L
authors.initials: JL
authors.lastname: Humm
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000528:radiation effects*; D002453:Cell Cycle / Q000528:radiation effects; D004273:DNA, Neoplasm / Q000378:metabolism; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D008223:Lymphoma / Q000473:pathology / Q000532:radiotherapy*; D051379:Mice; D016499:Radioimmunotherapy; D014407:Tumor Cells, Cultured
chemical_list: D004273:DNA, Neoplasm